INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 113 filers reported holding INTERSECT ENT INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,266,000 | -32.0% | 300,103 | -25.4% | 0.03% | -39.2% |
| Q4 2020 | $9,213,000 | +47.6% | 402,327 | +5.1% | 0.05% | +10.9% |
| Q3 2020 | $6,241,000 | +92.2% | 382,644 | +59.6% | 0.05% | +64.3% |
| Q2 2020 | $3,247,000 | -2.3% | 239,797 | -14.5% | 0.03% | -28.2% |
| Q1 2020 | $3,322,000 | -23.5% | 280,375 | +60.8% | 0.04% | +50.0% |
| Q4 2019 | $4,342,000 | +1042.6% | 174,386 | +679.9% | 0.03% | +766.7% |
| Q3 2019 | $380,000 | -91.9% | 22,361 | -84.7% | 0.00% | -90.3% |
| Q1 2019 | $4,702,000 | +1758.5% | 146,267 | +1527.5% | 0.03% | +1450.0% |
| Q4 2018 | $253,000 | -95.8% | 8,987 | -95.6% | 0.00% | -92.6% |
| Q3 2018 | $6,034,000 | -15.7% | 205,600 | +12.9% | 0.03% | -10.0% |
| Q1 2018 | $7,159,000 | +755.3% | 182,158 | +508.3% | 0.03% | +900.0% |
| Q2 2017 | $837,000 | +280.5% | 29,945 | +158.6% | 0.00% | +200.0% |
| Q1 2016 | $220,000 | -64.5% | 11,580 | -56.2% | 0.00% | -80.0% |
| Q3 2015 | $619,000 | – | 26,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
| Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
| Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
| Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
| Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
| Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
| FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
| MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |